Companies: 10,795·Total market cap: $144.5T
Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc.

EWTXNASDAQHealthcare● Active
$34.86
$-0.73(-2.05%)
Market Cap$3.8B
P/E Ratio
52W High$40.765
52W Low$12.15
Overview

Edgewise Therapeutics, Inc.(EWTX)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · EWTX · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Profit($0.00B)$0.00B$0.00B$0.00B$0.00B
Gross Margin %(computed)
Operating Expenses
R&D Expenses$0.15B$0.13B$0.09B$0.05B$0.03B
G&A Expenses$0.04B$0.03B$0.02B$0.02B$0.01B
Total Operating Expenses$0.19B$0.16B$0.11B$0.07B$0.04B
Operating Income($0.19B)($0.16B)($0.11B)($0.07B)($0.04B)
Operating Margin %(computed)
Interest Income$0.02B$0.03B$0.01B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.17B)($0.13B)($0.10B)($0.07B)($0.04B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($0.17B)($0.13B)($0.10B)($0.07B)($0.04B)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-1.63$-1.45$-1.57$-1.26$-0.86
Wtd Avg Shares0.10B0.09B0.06B0.05B0.05B
EBITDA($0.17B)($0.16B)($0.11B)($0.07B)($0.04B)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Edgewise Therapeutics, Inc.

关于Edgewise Therapeutics, Inc.(EWTX)损益表

Edgewise Therapeutics, Inc.(EWTX)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,EWTX实现营收$0.00B,毛利润($0.00B)(毛利率—),净利润($0.17B)(净利率—)。

常见问题

EWTX · 4 问

Edgewise Therapeutics, Inc.(EWTX)2025财年营收为$0.00B,同比down—%。

EWTX revenueEWTX salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08